Oncology and Immuno-Oncology Clinical Trials
Specialist Phase I–III Oncology Expertise
Oncology is one of our most established and deeply embedded therapeutic areas. We partner with biotech sponsors who need more than operational delivery they need a CRO that understands the science, anticipates complexity, and takes ownership from first engagement through close-out.
Our teams bring hands-on Phase 1 oncology experience, strong investigator relationships, and a pragmatic, problem-solving mindset. Sponsors get direct access to senior people who are closely involved in their study – not relayed updates through layers of project management.
Areas of deep expertise
Latest insights
-
Insight | Article
Understanding phase 1 oncology trials for impactful patient outcomes
In 2022, there were an estimated 20 million new cancer… Read more -
Insight | Blog
Tips for conducting early-phase cancer trials in Australia
As the fight against cancer continues, early-phase clinical trials are… Read more -
Whitepaper
The Benefits of US Biotechs Conducting Clinical Trials in Australia
Australia has quickly become a top destination for US biotech… Read more
Tumour types and indication experience
Our oncology trial experience includes:
Advanced solid tumours
Bladder cancer
Breast cancer
Gastro-oesophageal cancer
Head and neck cancer
Haematologic malignancies
Mesothelioma
Metastatic colorectal cancer
Metastatic melanoma
Non-small cell lung cancer (NSCLC)
Ovarian cancer
Prostate cancer (including multi-year ongoing programme)
Why Australia for Phase 1 Oncology?
Did you know:
Australia sets the pace globally for Phase 3 oncology start-up. We are extremely competitive on speed and our country’s multicultural population produces data with broader global applicability.